115 related articles for article (PubMed ID: 9486781)
1. Effectiveness of cisplatin, paclitaxel, and suramin against human malignant mesothelioma xenografts in athymic nude mice.
Chahinian AP; Mandeli JP; Gluck H; Naim H; Teirstein AS; Holland JF
J Surg Oncol; 1998 Feb; 67(2):104-11. PubMed ID: 9486781
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of the nude mouse model in mesothelioma based on a direct patient-xenograft comparison.
Chahinian AP; Kirschner PA; Gordon RE; Szrajer L; Holland JF
Cancer; 1991 Aug; 68(3):558-60. PubMed ID: 2065276
[TBL] [Abstract][Full Text] [Related]
3. Temsirolimus inhibits malignant pleural mesothelioma growth in vitro and in vivo: synergism with chemotherapy.
Hoda MA; Mohamed A; Ghanim B; Filipits M; Hegedus B; Tamura M; Berta J; Kubista B; Dome B; Grusch M; Setinek U; Micksche M; Klepetko W; Berger W
J Thorac Oncol; 2011 May; 6(5):852-63. PubMed ID: 21358348
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo therapeutic efficacy of the PPAR-γ agonist troglitazone in combination with cisplatin against malignant pleural mesothelioma cell growth.
Hamaguchi N; Hamada H; Miyoshi S; Irifune K; Ito R; Miyazaki T; Higaki J
Cancer Sci; 2010 Sep; 101(9):1955-64. PubMed ID: 20608936
[TBL] [Abstract][Full Text] [Related]
5. Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma.
Chahinian AP; Norton L; Holland JF; Szrajer L; Hart RD
Cancer Res; 1984 Apr; 44(4):1688-92. PubMed ID: 6423278
[TBL] [Abstract][Full Text] [Related]
6. Bcl-xL antisense oligonucleotide and cisplatin combination therapy extends survival in SCID mice with established mesothelioma xenografts.
Littlejohn JE; Cao X; Miller SD; Ozvaran MK; Jupiter D; Zhang L; Rodarte C; Smythe WR
Int J Cancer; 2008 Jul; 123(1):202-8. PubMed ID: 18360826
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of combination chemotherapy with cyclophosphamide, doxorubicin, and cisplatin for unresectable or metastatic malignant pleural mesothelioma.
Shin DM; Fossella FV; Umsawasdi T; Murphy WK; Chasen MH; Walsh G; Komaki R; McMurtrey MJ; Hong WK
Cancer; 1995 Dec; 76(11):2230-6. PubMed ID: 8635025
[TBL] [Abstract][Full Text] [Related]
8. [A case of remission in diffuse pleural mesothelioma induced by anticancer chemotherapy with cisplatin and adriamycin].
Kinoshita S; Yamashita T; Yagi M; Bando H; Tsubura E; Sano T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1872-6. PubMed ID: 4041164
[TBL] [Abstract][Full Text] [Related]
9. Pemetrexed-cisplatin combination in mesothelioma.
Reck M; Gatzemeier U
Expert Rev Anticancer Ther; 2005 Apr; 5(2):231-7. PubMed ID: 15877521
[TBL] [Abstract][Full Text] [Related]
10. Suramin inhibits the growth of malignant mesothelioma in vitro, and in vivo, in murine flank and intraperitoneal models.
Cook JW; Sterman DH; Singhal S; Smythe WR; Kaiser LR
Lung Cancer; 2003 Dec; 42(3):263-74. PubMed ID: 14644513
[TBL] [Abstract][Full Text] [Related]
11. Induction of apoptosis in malignant pleural mesothelioma cells by activation of the Fas (Apo-1/CD95) death-signal pathway.
Stewart JH; Nguyen DM; Chen GA; Schrump DS
J Thorac Cardiovasc Surg; 2002 Feb; 123(2):295-302. PubMed ID: 11828289
[TBL] [Abstract][Full Text] [Related]
12. Low-dose suramin enhanced paclitaxel activity in chemotherapy-naive and paclitaxel-pretreated human breast xenograft tumors.
Song S; Yu B; Wei Y; Wientjes MG; Au JL
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6058-65. PubMed ID: 15447990
[TBL] [Abstract][Full Text] [Related]
13. Augmentation of activity of cis-diamminedichloroplatinum(II) and mitomycin C by interferon in human malignant mesothelioma xenografts in nude mice.
Sklarin NT; Chahinian AP; Feuer EJ; Lahman LA; Szrajer L; Holland JF
Cancer Res; 1988 Jan; 48(1):64-7. PubMed ID: 2446742
[TBL] [Abstract][Full Text] [Related]
14. Taxol inhibits growth of mesothelioma xenografts.
Lee JM; Bruckner HW; Szrajer L; Brenne U; Schindelheim G; Andreotti PE
Anticancer Res; 1995; 15(3):693-6. PubMed ID: 7645945
[TBL] [Abstract][Full Text] [Related]
15. SOCS-1 gene delivery cooperates with cisplatin plus pemetrexed to exhibit preclinical antitumor activity against malignant pleural mesothelioma.
Iwahori K; Serada S; Fujimoto M; Ripley B; Nomura S; Mizuguchi H; Shimada K; Takahashi T; Kawase I; Kishimoto T; Naka T
Int J Cancer; 2013 Jan; 132(2):459-71. PubMed ID: 22532243
[TBL] [Abstract][Full Text] [Related]
16. Phase-II study with the combination of cisplatin and doxorubicin in advanced malignant mesothelioma of the pleura.
Henss H; Fiebig HH; Schildge J; Arnold H; Hasse J
Onkologie; 1988 Jun; 11(3):118-20. PubMed ID: 3045724
[TBL] [Abstract][Full Text] [Related]
17. A phase II study evaluating the cisplatin and epirubicin combination in patients with unresectable malignant pleural mesothelioma.
Berghmans T; Lafitte JJ; Paesmans M; Stach B; Berchier MC; Wackenier P; Lecomte J; Collon T; Mommen P; Sculier JP;
Lung Cancer; 2005 Oct; 50(1):75-82. PubMed ID: 16005104
[TBL] [Abstract][Full Text] [Related]
18. [A case of malignant pleural mesothelioma and its sensitivity tests for anti-cancer drugs].
Asakura S; Matsui T; Tatsumi A; Fujio A; Kitano M; Kobashi Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Jul; 26(7):695-9. PubMed ID: 3149385
[No Abstract] [Full Text] [Related]
19. The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systematic review and practice guideline.
Ellis P; Davies AM; Evans WK; Haynes AE; Lloyd NS;
J Thorac Oncol; 2006 Jul; 1(6):591-601. PubMed ID: 17409924
[TBL] [Abstract][Full Text] [Related]
20. Nontoxic suramin treatments enhance docetaxel activity in chemotherapy-pretreated non-small cell lung xenograft tumors.
Lu Z; Wientjes TS; Au JL
Pharm Res; 2005 Jul; 22(7):1069-78. PubMed ID: 16028007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
